Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06827704 · ClinicalTrials.gov registry record · NA
Physical Activity Targeting Metabolic Syndrome for Prevention of Breast Cancer in SAI Women
A NA study of Physical Activity and Metabolic Syndrome, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 96
- Enrollment target
- 2
- Study locations
NCT06827704: Recruiting NA study of Physical Activity and Metabolic Syndrome, sponsored by Rush University Medical Center.
NCT06827704 is a NA study of Physical Activity and Metabolic Syndrome that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 96 participants, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (73% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06827704, a NA study of Physical Activity and Metabolic Syndrome, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study aims to to improve physical activity and metabolic outcomes for breast cancer prevention in South Asian Indian immigrant women.
Primary Outcome
Determine the independent and combined efficacies of PAM and Dance at 12 and 24 weeks on lifestyle PA (steps/day \[ActiGraph\] in midlife SAI women.
Conditions Studied
Interventions
- BEHAVIORAL Enhanced physical activity monitor which is Fitbit watch with mobile App
- BEHAVIORAL Bollywood-style group dance
- BEHAVIORAL PAMDance
Study Locations (2)
Illinois
- Rush University College of Nursing - Chicago
- Rush University College of Nursing - Sugar Grove
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06827704 shows while recruiting
NCT06827704 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (73% lower).
The record links to 3 conditions, with Physical Activity appearing as the primary indexed condition, and to 3 interventions - of which Enhanced physical activity monitor which is Fitbit watch with mobile App is the first listed.
NCT06827704 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06827704 about?
NCT06827704 is a clinical study titled "Physical Activity Targeting Metabolic Syndrome for Prevention of Breast Cancer in SAI Women". This study aims to to improve physical activity and metabolic outcomes for breast cancer prevention in South Asian Indian immigrant women.
What is the current status of trial NCT06827704?
This trial is currently recruiting. It is a NA study. The enrollment target is 96 participants. The study started on 2025-05-01. Estimated completion is 2026-12-31.
What conditions does trial NCT06827704 study?
This clinical trial studies the following conditions: Physical Activity, Metabolic Syndrome, Breast Cancer Prevention.
What interventions are being tested in trial NCT06827704?
The interventions under investigation include: Enhanced physical activity monitor which is Fitbit watch with mobile App (BEHAVIORAL), Bollywood-style group dance (BEHAVIORAL), PAMDance (BEHAVIORAL).
Who is sponsoring clinical trial NCT06827704?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06827704 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Physical Activity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06827704's enrollment target sits among peer trials
96 67th of 131 higher than 64 of 131 other Physical Activity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Physical Activity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
RECRUITING · NA
-
Va Meh Du: A Sports-based Mental Health Promotion Intervention for Karenni Refugees
RECRUITING · NA
-
Teen Mom Study Feasibility Trial
RECRUITING · NA
-
The Fit With Us Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI